Novartis Splits Pharma Biz In Two, Parts With Drug Exec
Novartis AG said Tuesday it will be splitting its pharmaceuticals business in two and parting with the current head of the division, after recently facing high-profile scrutiny for the Swiss drugmaker's...To view the full article, register now.
Already a subscriber? Click here to view full article